Bayer AG Faces Significant Drop After Court Ruling

In a dramatic start to the week, Bayer AG experienced a sharp decline of over 6% in early trading. This downturn comes in the wake of a Georgia jury's decision in a civil lawsuit against Monsanto Co., a subsidiary of Bayer. The jury awarded the plaintiff more than $2 billion, concluding that Monsanto's widely used weed killer, Roundup, was responsible for the plaintiff's cancer.

Market Reaction: By 9:05 am CET, Bayer's shares had fallen by 6.83%, trading at €22.49. This verdict marks another challenging moment for Bayer in its ongoing legal battles related to Roundup.